SGLT2 Inhibitors – Diabetologia
Frontiers | Effect of Sodium-Glucose Co-transporter 2 Inhibitors on Bone Metabolism and Fracture Risk | Pharmacology
Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure | Heart
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation - American Journal of Kidney Diseases
IJMS | Free Full-Text | Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection
A review of the mechanism of action, metabolic profile and haemodynamic effects of sodium‐glucose co‐transporter‐2 inhibitors - Brown - 2019 - Diabetes, Obesity and Metabolism - Wiley Online Library
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus | Circulation
The mechanism of SGLT2 inhibition in glucose control - PACE-CME
Mode of action of SGLT2 inhibitors in the kidney. Copied with... | Download Scientific Diagram
SGLT2 Inhibitors and nephroprotection in diabetic kidney disease: From mechanisms of action to the latest evidence in the literature
SciELO - Brasil - SGLT-2 inhibitors in diabetes: a focus on renoprotection SGLT-2 inhibitors in diabetes: a focus on renoprotection
Schematic diagram showing conventional mechanisms of action of SGLT2... | Download Scientific Diagram
Renoprotective effects of sodium-glucose cotransporter-2 inhibitors - Kidney International
The potential role and rationale for treatment of heart failure with sodium–glucose co‐transporter 2 inhibitors - Butler - 2017 - European Journal of Heart Failure - Wiley Online Library
Sodium glucose cotransporter 2 inhibitors: mechanisms of action in heart failure | SpringerLink
SGLT2 inhibitors: a narrative review of efficacy and safety
Potential Mechanisms of Sodium-Glucose Co-Transporter 2 Inhibitor-Related Cardiovascular Benefits - The American Journal of Medicine
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control | Nature Reviews Cardiology
SGLT2 Inhibition in the Diabetic Kidney—From Mechanisms to Clinical Outcome | American Society of Nephrology
Mechanisms of SGLT2 (Sodium-Glucose Transporter Type 2) Inhibition-Induced Relaxation in Arteries From Human Visceral Adipose Tissue | Hypertension
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 ( SGLT2) Inhibitors | Semantic Scholar
